IP Library Granted Patent US 11,420,986
Granted Patent B2
US 11,420,986 · App. 15/772,759 · Granted Aug 23, 2022

Functionalized mesoporous silica via an aminosilane surfactant ion exchange reaction: controlled scaffold design and nitric oxide release

Inventors: Mark H. Schoenfisch (Chapel Hill, NC); Robert J. Soto (Durham, NC)
Assignee: The University of North Carolina at Chapel Hill
C07F7/188A61K33/00A61K47/24B01J20/103B01J20/28007B01J20/28016B01J20/28083B01J20/3085C01B21/24C01B33/18C07F7/1804C01P2004/61C01P2004/62C01P2004/64C01P2006/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,420,986
App. No.
15/772,759
Granted
Aug 23, 2022
Kind
B2
Abstract

Nitric oxide-releasing mesoporous silica nanoparticles (MSNs) were prepared using an aminosilane-template surfactant ion exchange reaction. Initially, bare silica particles were synthesized under basic conditions in the presence of cetyltrimethylammonium bromide (CTAB). These particles were functionalized with nitric oxide (NO) donor precursors via the addition of aminosilane directly to the particle sol, and a commensurate ion exchange reaction between the cationic aminosilanes and CTAB. N-diazeniumdiolate NO donors were formed at the secondary amines to yield NO-releasing silica MSNs. Tuning of the ion exchange-based MSN modification approach allowed for the preparation of monodisperse particles ranging from 30 to 1100 nm. Regardless of size, the MSNs stored appreciable levels of NO (0.4-1.5 μmol/mg) with tunable NO-release durations (1-33 h) dependent on the aminosilane modification. The range of MSN sizes and NO release demonstrate the versatility of this strategy.

Claims (38)

1. A method of producing nitric oxide (NO)-releasing mesoporous silica particles, wherein said method comprises:

reacting an alkoxysilane with an alkylammonium surfactant in the absence of added organoaminosilane to form a turbid mixture comprising mesoporous silica nanoparticles (MSN) in a colloidal sol;

adding an organoaminosilane to the MSN in the colloidal sol to modify the MSN via an ion exchange reaction of the organoaminosilane and an alkylammonium ion and form amino-functionalized MSN; and

reacting the amino-functionalized MSN with NO gas to produce NO-releasing MSN.

2. The method of claim 1 , wherein the alkoxysilane is one or more of tetraethylorthosilicate, methyltrimethoxysilane, ethyltrimethoxysilane, and isobutyltrimethoxysilane and the alkylammonium surfactant is a cetyltrimethylammonium halide.

3. The method of claim 2 , wherein the cetyltrimethylammonium halide is cetyltrimethylammonium bromide.

4. The method of claim 1 , wherein the ion exchange reaction is a cation exchange reaction.

5. The method of claim 1 , wherein the organoaminosilane is a compound of Formula I:

wherein z is 0, 1, or 2; and R 1 is

wherein R 2 and R 3 are each independently H, CH 3 , (CH 2 ) 2-5 NH 2 , or (CH 2 ) 2-5 NH(CH 2 ) 2-5 NH 2 .

6. The method of claim 1 , wherein the organoaminosilane is one or more of:

N-(2-aminoethyl)-3-aminopropyltrimethoxysilane,

N-(6-aminohexyl)aminopropyl trimethoxysilane,

(3-Aminopropyl)triethoxysilane,

N-methylaminopropyltrimethoxysilane,

and

(3-trimethoxysilyl-propyl)diethylenetriamine or combinations thereof.

7. The method of claim 1 , wherein the method produces the NO-releasing MSN via

a one-pot synthesis.

8. The method of claim 1 , wherein the NO-releasing MSN have a diameter-between about 30 nm and 1100 nm.

9. The method of claim 1 , wherein the NO-releasing MSN are substantially monodisperse in size.

10. The method of claim 1 , wherein the NO-releasing MSN have a diameter of about 30 nm, 150 nm, 350 nm and/or 1100 nm.

11. The method of claim 1 , wherein the alkylammonium surfactant is:

a. a linear alkylammonium salt having a structure of: [C n H 2n+1 (CH 3 ) 3 N] + Br − or [C n H 2n+1 (C 2 H 5 ) 3 N] + Br − where n=8, 10, 12, 14, 16, 18, 20, 22;

b. a geminal salt having a structure of: [C n H 2n+1 (CH 3 ) 2 N—(CH 2 ) 5 —N(CH 3 ) 2 —C m H m+1 ] + Br − where n=m=12, 14, 16, 18, 20, 22 and s=2-12; or

c. a divalent surfactant having a structure of: [C n H 2n+1 (CH 3 ) 2 N—C m H 2m+1 (CH 3 ) 3 N] 2+ where n+m=8, 10, 12, 14, 16, 18, 20, 22.

12. The method of claim 1 , wherein the NO-releasing MSN are insensitive to ambient humidity.

13. The method of claim 1 , wherein the amino-functionalized MSN have a polydispersity index (PDI) of less than 0.20.

14. A method of producing nitric oxide (NO)-releasing mesoporous silica particles, wherein said method comprises:

reacting an alkoxysilane with an alkylammonium surfactant to form mesoporous silica nanoparticles (MSN) in a colloidal sol;

adding an organoaminosilane to the MSN in the colloidal sol to exchange via an ion exchange reaction of the organoaminosilane and an alkylammonium ion to form amino-functionalized MSN; and

reacting the amino-functionalized MSN with NO gas to produce NO-releasing MSN,

wherein the amino-functionalized MSN have a polydispersity index (PDI) of less than 0.20.

15. A method of producing nitric oxide (NO)-releasing mesoporous silica particles, wherein said method comprises:

reacting an alkoxysilane with an alkylammonium surfactant to form mesoporous silica nanoparticles (MSN) in a colloidal sol;

adding an organoaminosilane to the MSN in the colloidal sol to exchange via an ion exchange reaction of the organoaminosilane and an alkylammonium ion to form amino-functionalized MSN; and

reacting the amino-functionalized MSN with NO gas to produce NO-releasing MSN;

wherein the alkoxysilane and the alkylammonium surfactant are reacted for at least 15 minutes before the addition of the organoaminosilane.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 070776/0692 →
CORRECTION BY DECLARATION ERRONEOUSLY FILED AGAINST REEL 066350/FRAME 0942 Recorded Nov 12, 2024
From: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
To: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Reel/Frame 069386/0419 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2024
From: NOVAN, INC.
To: LNHC, INC.
Reel/Frame 066350/0942 →
SECURITY INTEREST Recorded Oct 18, 2023
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; PFENEX INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065271/0025 →
CONFIRMATORY LICENSE Recorded Oct 23, 2018
From: UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 047290/0623 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2018
From: SCHOENFISCH, MARK H.; SOTO, ROBERT J.
To: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Reel/Frame 045695/0213 →
Continuity (2)
Provisional Application 62249428 · Nov 2, 2015
Related Publication 20180319822A1 · Nov 8, 2018